Using naltrexone implants in the management of the pregnant heroin user

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 42, Issue 5, 2002, Pages 569-573

  Hulse, G ^a   O'Neil, G K ^a,b  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; NALTREXONE; POLYLACTIDE;

ADULT; ARTICLE; AUSTRALIA; CHILDBIRTH; CLINICAL ARTICLE; CONCEPTION; DRUG IMPLANT; DRUG USE; DRUG WITHDRAWAL; FEMALE; FETUS DEVELOPMENT; GESTATION PERIOD; HEROIN DEPENDENCE; HUMAN; MATERNAL CARE; MEDICAL RECORD; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0036853672     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0004-8666.2002.548_14.x     Document Type: Article

References (18)

1. NIDA's naltrexone research program. NIDA Res Monogr. 1976 Sep; (9): 5-11.
2. Tennant FS Jr, Rawson RA, Cohen AJ, Mann A. Clinical experience with naltrexone in suburban opioid addicts. J Clin Psychiatry. 1984 Sep; 45 (9 Pt 2): 42-45.
3. Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust. 1999 Jul 5; 171 (1): 26-30.
4. Azarian A, Papiasvilli A, Joseph H. A study of the use of clonidine and naltrexone in the treatment of opiod addiction in the former USSR. J Addict Dis. 1994; 13 (1): 35-52.
5. San L, Pomarol G, Peri JM, Olle JM, Cami J. Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts. Br J Addict. 1991 Aug; 86 (8): 983-990.
6. Anton RF, Hogan I, Jalali B, Riordan CE, Kleber HD. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug Alcohol Depend. 1981 Sep; 8 (2): 157-168.
7. Hulse GK, Basso MR. The association between naltrexone compliance and daily supervision. Drug & Alcohol Review 2000 Mar; 19 (1): 41-48.
8. Hulse G, O'Neill G. A possible role for implantable naltrexone in the management of the high risk pregnant heroin user. Aust N Z J Obstet Gynaec. 2002 Feb; 42 (1): 93-94.
9. Hulse G, O'Neill G, Pereira C, Brewer C. Obstetric and neonatal outcomes associated with maternal naltrexone exposure. Aust N Z J Obstet Gynaec. 2001 Nov; 41 (4): 424-428.
10. Kandall SR, Albin S, Gartner LM, Lee KS, Eidelman A, Lowinson J. The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev. 1977 Oct; 1 (2): 159-169.
11. Connaughton JF, Reeser D, Schut J, Finnegan LP. Perinatal addiction: outcome and management. Am J Obstet Gynecol. 1977 Nov 15; 129 (6): 679-685.
12. Ellwood DA, Sutherland P, Kent C, O'Connor M. Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic. Aust N Z J Obstet Gynaecol. 1987 May; 27 (2): 92-98.
13. Keith LG, MacGregor S, Friedell S, Rosner M, Chassnoff IJ, Sciarra JJ. Substance abuse in pregnant women: recent experience at the Perinatal Centre for Chemical Dependence of Northwestern Memorial Hospital. Obstet Gynecol. 1989 May; 73 (5 Pt 1): 715-720.
14. Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birthweight. Addiction. 1997 Nov; 92 (11): 1571-1579.
15. Hulse GK, Milne E, English DR, Holman CD. Assessing the relationship between maternal opiate use and neonatal mortality. Addiction 1998 Jul; 93 (7): 1033-1042.
16. Strauss ME, Andresko M, Stryker JC, Wardell JN, Dunkel LD. Methadone maintenance during pregnancy: pregnancy, birth and neonate characteristics. Am J Obstet Gynecol. 1974 Dec 1; 120 (7): 895-900.
17. Vargas GC, Pildes RS, Vidyasagar D, Keith LG. Effect of maternal heroin addiction on 67 liveborn neonates. Withdrawal symptoms, small body size and small head circumference were frequent findings. Clin Pediatr (Phila). 1975 Aug; 14 (8): 751-757.
18. Lam S, To W, Duthie SJ, Ma HK. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. Aust N Z J Obstet Gynaecol. 1992 Aug; 32 (3): 216-221.